Market Research Report
Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||507582|
|Published||Content info||70 Pages
Delivery time: 1-2 business days
|Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021|
|Published: May 24, 2017||Content info: 70 Pages||
Antibodies that attack healthy proteins in the nucleus cells are called antinuclear antibodies. When a person has an autoimmune disease such as rheumatoid arthritis or systemic lupus erythematosus (SLE), the immune system produces antibodies that will attach to the cells, often causing damage to them. Some of the ANA tests are EUROPLUS ANA Mosaic 20A, QUANTA Lite ANA, BioPlex 2200 ANA Screen. The global ANA testing market is expected to benefit from the growing incidence of several autoimmune diseases worldwide.
Technavio's analysts forecast the global anti-nuclear antibody (ANA) testing market to grow at a CAGR of 7.13 % during the period 2017-2021.
The report covers the present scenario and the growth prospects of the global anti-nuclear antibody (ANA) testing market for 2017-2021. To calculate the market size, the report considers the new installations/sales/volume/value and replacement/ services of anti-nuclear antibody testing market.
The market is divided into the following segments based on geography:
Technavio's report, Global Anti-Nuclear Antibody (ANA) Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.